A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells
Clinical trial NCT03856996 · COMPLETED
Trial details
- NCT number
- NCT03856996
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-23
- Primary completion
- 2021-03-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.